These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 9193397)
1. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials. Cleland JG; Erhardt L Lancet; 1997 Jun; 349(9067):1767. PubMed ID: 9193397 [No Abstract] [Full Text] [Related]
2. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials. Malik M; Camm AJ Lancet; 1997 Jun; 349(9067):1767-8. PubMed ID: 9193398 [No Abstract] [Full Text] [Related]
3. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Gambhir DS Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817 [No Abstract] [Full Text] [Related]
4. [Anti-arrhythmia therapy after myocardial infarct: preliminary results of EMIAT and CAMIAT studies]. Kuck KH Z Kardiol; 1996; 85 Suppl 6():107-13. PubMed ID: 9064953 [TBL] [Abstract][Full Text] [Related]
5. [Management of patients with risk of sudden death. The amiodarone example]. Djian J Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):67-74. PubMed ID: 7944868 [TBL] [Abstract][Full Text] [Related]
7. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials. Incalzi RA; Gemma A; Carbonin PU Lancet; 1997 Jun; 349(9067):1768; author reply 1769-70. PubMed ID: 9193399 [No Abstract] [Full Text] [Related]
8. [Antiarrhythmic therapy in patients with heart failure]. Faber TS; Zehender M Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993 [TBL] [Abstract][Full Text] [Related]
9. What have clinical trials taught us about proarrhythmia? Skanes AC; Green MS Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725 [TBL] [Abstract][Full Text] [Related]
10. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. Yap YG; Duong T; Bland M; Malik M; Torp-Pedersen C; Køber L; Connolly SJ; Marchant B; Camm J Eur Heart J; 2005 Jul; 26(14):1385-93. PubMed ID: 15914501 [TBL] [Abstract][Full Text] [Related]
12. Amiodarone and mortality in CHF and post-MI. Zamorski M J Fam Pract; 1998 Mar; 46(3):196-7. PubMed ID: 9519009 [No Abstract] [Full Text] [Related]
13. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators. Lancet; 1997 Nov; 350(9089):1417-24. PubMed ID: 9371164 [TBL] [Abstract][Full Text] [Related]
14. [Cardiac Arrhythmia Suppression Trial: a disappointment?]. Magalhães CO Arq Bras Cardiol; 1990 Sep; 55(3):153-4. PubMed ID: 2095719 [No Abstract] [Full Text] [Related]
16. Does amiodarone reduce sudden death and cardiac mortality after myocardial infarction? The European Myocardial Infarct Amiodarone Trial (EMIAT). Schwartz PJ; Camm AJ; Frangin G; Janse MJ; Julian DG; Simon P Eur Heart J; 1994 May; 15(5):620-4. PubMed ID: 8056000 [No Abstract] [Full Text] [Related]
17. [Long-term effect of amiodarone therapy following myocardial infarct in patients with complex ventricular arrhythmias]. Kiowski W; Brunner H; Pfisterer M; Burckhardt D; Burkart F Schweiz Med Wochenschr; 1993 Mar; 123(12):533-6. PubMed ID: 8475360 [TBL] [Abstract][Full Text] [Related]
18. [What information is given by controlled clinical trials (pharmacological and nonpharmacological) for anti-arrhythmia therapy in the prevention of sudden death?]. Naccarella F; Croci F G Ital Cardiol; 1996 Nov; 26(11):1345-64. PubMed ID: 9036037 [No Abstract] [Full Text] [Related]
19. [Amiodarone and secondary prevention. The EMIAT study]. Munoz A Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():67-9. PubMed ID: 1726998 [TBL] [Abstract][Full Text] [Related]